About Apoptrol, llc

Last Updated:

Apoptrol, LLC. (http://www.apoptrol.com/) is a biotechnology company specializing in the development of small molecules for the inhibition of cell death in conjunction with a second biological function, termed DFI's or Dual Function Inhibitors, for use in Biomedical Research. Targeted areas for future treatment include Organ Transplant, Stroke, Neurological Disorders, such as Alzheimer's and Parkinson's Disease, Disorders of the Eye, such as Macular Degeneration, Retinitis Pigmentosa, and Cataracts, Type I Diabetes, and Spinal Cord Injury, among many others. Apoptrol, LLC was licensed in 2007 to Founder and President, Dr. Thomas L. Brown, Ph.D., and operates in conjunction with Dr. David R. Cool, Ph.D. (Head of Proteomics), and Dr. Eugene Hern, Ph.D. (Chief Operating Officer). The Apoptrol corporate office is located at 2661 Commons Boulevard, Beavercreek, Ohio, U.S.A., 45431.

Apoptrol, LLC
PO Box 32, Enon, OH 45323-0032
Phone: 937-623-8729